Efficacy of Statins Among Major Depressive Disorder

PHASE3RecruitingINTERVENTIONAL
Enrollment

145

Participants

Timeline

Start Date

October 1, 2022

Primary Completion Date

December 4, 2024

Study Completion Date

December 31, 2025

Conditions
Major Depressive DisorderMDD
Interventions
DRUG

Rosuvastatin 10 mg tablet.

"The dose of rosuvastatin was derived from literature describing the doses at which the agents' targeted actions are effective and safe. The 10- mg rosuvastatin dose reflects the lowest prescribed therapeutic dose A serum cholesterol level will be drawn from the whole participants and sent to the central laboratories of El-Demerdash hospital at baseline and at week 12.~At each visit, participants will be requested to return all unused investigational products. Adherence to medication will be assessed by a pill count."

DRUG

Sertraline Pill

Both control and intervention group will receive the sertraline as a standard therapy

Trial Locations (1)

+02

RECRUITING

El demerdash hospital, Cairo

All Listed Sponsors
lead

Ain Shams University

OTHER